Back to search

Canada· CA-DIN-02505843

SANDOZ TERIFLUNOMIDE

A teriflunomide product containing teriflunomide, registered in Canada by SANDOZ CANADA INCORPORATED. The same ATC class is registered in 14 of our 19 countries.

ATC L04AK02

Checked against Health Canada Drug Product Database (Canada) on

Informational only — not a medical device.

SOURCE REGISTER · CAHealth Canada Drug Product Database (Ca…normalisedSANDOZ TERIFLUNOMIDEATCL04AK02REGISTER NO.CA-DIN-02505843PACKS LISTED0CHECKEDOctober 1, 2026

Where it is registered

Teriflunomide is registered in 14 of 19 countries.

Countries holding a registration under ATC L04AK02 (teriflunomide), each read from that country’s own register.

  • This record: Canada, from Health Canada Drug Product Database (Canada)
  • 9 of them publish a price we can compare per daily dose

Teriflunomide · ATC L04AK02

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of teriflunomide costs, country by country.

Normalised to the WHO defined daily dose (14 mg), the median price runs from $18.33 in Switzerland to $28.01 in Italy — a ×1.5 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Teriflunomide · price per daily dose (14 mg)

USD · FX 28 Sept 2026

  • IT Italy$28.01
  • CH Switzerland$18.33
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Health Canada Drug Product Database (Canada)
Active substance
TERIFLUNOMIDE
Manufacturer
SANDOZ CANADA INCORPORATED
Country
Canada (CA)
ATC code
L04AK02
ATC class
Teriflunomide
Defined daily dose
14 mg, O
Reimbursed
Not published by this register
Source register
Health Canada Drug Product Database (Canada)
Last checked
October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

668 interactions on record for teriflunomide.

Graded by severity as the source publishes them — 542 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Teriflunomide · interactions on record

668 records

  • 542 severe
  • 116 moderate
  • 10 minor

Most severe, free to view

  • ClotrimazoleA01AB18severe
  • Chenodeoxycholic acidA05AA01severe
  • PrednisoloneA07EA01severe
  • HydrocortisoneA07EA02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Teriflunomide in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All teriflunomide products

Authorised across Europe · EMA

The same active substance is authorised in 31 EEA countries. Names it is sold under:

  • Austria · Terebyo, Teriflunomid +pharma
  • Belgium · Terebyo, Teriflunomide Eg
  • Bulgaria · Terebyo, Teriflunomide Msn
  • Cyprus · Aregalu, Arogio
  • Czechia · Aregalu, Boxarid
  • Germany · Terebyo, Teriflago
  • Denmark · Clefirem, Teriflunomid Devatis
  • Estonia · Aregalu, Boxarid
  • Spain · Clefirem, Teriflunomida Aurovitas
  • Finland · Clefirem, Teriflunomide Avansor
  • France · Terebyo, Teriflunomide Arrow
  • United Kingdom (Northern Ireland) · Teriflunomide, Teriflunomide Abdi
  • Greece · Aregalu, Arogio
  • Croatia · Aregalu, Telirem
  • Hungary · Aregalu, Arogio
  • Ireland · Teriflunomide Clonmel
  • Iceland · Aubagio, Feple
  • Italy · Clefirem, Terebyo
  • Liechtenstein · Aubagio, Teriflunomide Accord
  • Lithuania · Aregalu, Boxarid
  • Luxembourg · Teriflunomide Eg, Teriflunomide Eg (Eurogenerics)
  • Latvia · Aregalu, Boxarid
  • Malta · Telirem, Tergio
  • Netherlands · Teriflox, Teriflunomide Abdi
  • Norway · Aubagio, Clefirem
  • Poland · Aregalu, Boxarid
  • Portugal · Teriflunomida Basi, Teriflunomida Bluepharma
  • Romania · Aregalu, Boxarid
  • Sweden · Clefirem, Teriflunomid Devatis
  • Slovenia · Aregalu, Clefirem
  • Slovakia · Aregalu, Boxarid

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/5cc737d6-6ea1-4d4a-8e3e-902e7a5d1111
GET /v1/drugs/5cc737d6-6ea1-4d4a-8e3e-902e7a5d1111?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "02505843",
  "form": "TABLET",
  "class": "Human",
  "routes": [
    "ORAL"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "L04AK02",
  "schedule": [
    "Prescription"
  ],
  "drug_code": "99522",
  "strengths": [
    "14 MG"
  ],
  "ahfs_class": null,
  "substances": [
    "TERIFLUNOMIDE"
  ],
  "product_categorization": null
}

See everything about teriflunomide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.